DCP
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathVQ Biomedical is developing a minimally-invasive intravascular catheter that delivers supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure, providing gas exchange independent of the lungs.
BiotechHealthtechMedical DevicesApex, US
Galen Robertson(Co-founder & CEO)Tobias Straube(Co-founder & Chief Medical Officer)Stewart Farling(Co-founder & Lead Engineer)inMarc Deshusses(Co-founder & Principal Scientist)Bruce Klitzman(Co-founder & Scientific Advisor)
BoardDaniel E. Estay(Director)
Co-investorsDuke Capital PartnersWolfpack Investor Network
Portfolio news
latest coverage across their companiesVQ Biomedical · pulse2.com · Apr 2, 2025
Fund performance · per public LP disclosures · 2
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| DCP Capital Partners II LPLPs: Florida State Board of Administration, Ewing Marion Kauffman Foundation | 2022 | — | 6.6% | 1.11x | 0.08x |
| DCP ILPs: The Regents of the University of California | 2018 | — | 5.8% | 1.17x | 0.59x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).